Glucagon Therapy

Glucagon Therapy is a medical intervention within antidote therapy that involves the administration of glucagon to counteract the effects of beta-blocker or calcium channel blocker toxicity by stimulating adenylate cyclase independently of beta-adrenergic receptors.

953

Publications

43.7K

Citations

3.7K

Authors

1K

Institutions

Publications per year

2017–2026

130

Authors

3.7K

  1. JJ
    Jens J. Holst

    University of Copenhagen, Denmark

    32 publications · 2.1K citations

    24

    h-index

  2. RH
    Roger H. Unger

    The University of Texas Southwestern Medical Center, United States

    14 publications · 1.3K citations

    12

    h-index

  3. SM
    Stanley M. Chernish

    Indiana University – Purdue University Indianapolis, United States

    14 publications · 535 citations

    12

    h-index

  4. FK
    Filip K. Knop

    Gentofte Hospital, Denmark

    10 publications · 454 citations

    10

    h-index

  5. WK
    W. Kenneth Ward

    Legacy Health, United States

    9 publications · 475 citations

    9

    h-index

1–5 of 3.7K

Venues

  1. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 44 publications · 2.5K citations

    27

    h-index

  2. Diabetes

    48 publications · 3.2K citations

    27

    h-index

  3. Diabetes Care

    30 publications · 3.3K citations

    26

    h-index

  4. Diabetes Obesity and Metabolism

    33 publications · 1.6K citations

    24

    h-index

  5. PubMed

    Repository · 61 publications · 1.6K citations

    23

    h-index

1–5